![Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial - The Lancet Oncology Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/12de7d63-5adc-478c-bba4-98b4ba431258/gr1.gif)
Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial - The Lancet Oncology
![Mortality and biochemical recurrence after surgery, brachytherapy, or external radiotherapy for localized prostate cancer: a 10-year follow-up cohort study | Scientific Reports Mortality and biochemical recurrence after surgery, brachytherapy, or external radiotherapy for localized prostate cancer: a 10-year follow-up cohort study | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-022-16395-w/MediaObjects/41598_2022_16395_Fig1_HTML.png)
Mortality and biochemical recurrence after surgery, brachytherapy, or external radiotherapy for localized prostate cancer: a 10-year follow-up cohort study | Scientific Reports
![Superior metastasis-free survival for patients with high-risk prostate cancer treated with definitive radiation therapy compared to radical prostatectomy: A propensity score-matched analysis - Advances in Radiation Oncology Superior metastasis-free survival for patients with high-risk prostate cancer treated with definitive radiation therapy compared to radical prostatectomy: A propensity score-matched analysis - Advances in Radiation Oncology](https://www.advancesradonc.com/cms/attachment/f38080ae-53b3-4692-b810-adf56cf028bb/adro156-fig-0001_lrg.jpg)
Superior metastasis-free survival for patients with high-risk prostate cancer treated with definitive radiation therapy compared to radical prostatectomy: A propensity score-matched analysis - Advances in Radiation Oncology
![The Comparative Outcomes of Radical Prostatectomy versus Radiotherapy for Nonmetastatic Prostate Cancer: A Longitudinal, Population-Based Analysis | Journal of Urology The Comparative Outcomes of Radical Prostatectomy versus Radiotherapy for Nonmetastatic Prostate Cancer: A Longitudinal, Population-Based Analysis | Journal of Urology](https://www.auajournals.org/cms/asset/aa25306b-2f57-4c90-98f9-f7e2c14e2cba/ju.0000000000000805f1.gif)
The Comparative Outcomes of Radical Prostatectomy versus Radiotherapy for Nonmetastatic Prostate Cancer: A Longitudinal, Population-Based Analysis | Journal of Urology
![Frontiers | Comparison of Oncological Outcomes Between Radical Prostatectomy and Radiotherapy by Type of Radiotherapy in Elderly Prostate Cancer Patients Frontiers | Comparison of Oncological Outcomes Between Radical Prostatectomy and Radiotherapy by Type of Radiotherapy in Elderly Prostate Cancer Patients](https://www.frontiersin.org/files/Articles/708373/fonc-11-708373-HTML/image_m/fonc-11-708373-g001.jpg)
Frontiers | Comparison of Oncological Outcomes Between Radical Prostatectomy and Radiotherapy by Type of Radiotherapy in Elderly Prostate Cancer Patients
![Definitive external-beam radiotherapy versus radical prostatectomy in clinically localized high-risk prostate cancer: a retrospective study | BMC Urology | Full Text Definitive external-beam radiotherapy versus radical prostatectomy in clinically localized high-risk prostate cancer: a retrospective study | BMC Urology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12894-018-0432-6/MediaObjects/12894_2018_432_Fig3_HTML.png)
Definitive external-beam radiotherapy versus radical prostatectomy in clinically localized high-risk prostate cancer: a retrospective study | BMC Urology | Full Text
![Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial - The Lancet Oncology Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/fecc61fc-6781-4bed-aaf2-761274255384/gr1_lrg.jpg)
Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial - The Lancet Oncology
![Frontiers | Early Mortality of Prostatectomy vs. Radiotherapy as a Primary Treatment for Prostate Cancer: A Population-Based Study From the United States and East Germany Frontiers | Early Mortality of Prostatectomy vs. Radiotherapy as a Primary Treatment for Prostate Cancer: A Population-Based Study From the United States and East Germany](https://www.frontiersin.org/files/Articles/501261/fonc-09-01451-HTML-r1/image_m/fonc-09-01451-g001.jpg)
Frontiers | Early Mortality of Prostatectomy vs. Radiotherapy as a Primary Treatment for Prostate Cancer: A Population-Based Study From the United States and East Germany
![Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer | Journal of Urology Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer | Journal of Urology](https://www.auajournals.org/cms/asset/adaee361-3a82-4903-92e0-c49512324226/juro.2022.207.issue-2.cover.jpg)
Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer | Journal of Urology
![Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial - The Lancet Oncology Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/3eef8e6b-8d36-49d6-930b-a920063bbd48/gr1.gif)
Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial - The Lancet Oncology
![Mechanisms, mitigation, and management of urinary toxicity from prostate radiotherapy - The Lancet Oncology Mechanisms, mitigation, and management of urinary toxicity from prostate radiotherapy - The Lancet Oncology](https://www.thelancet.com/cms/attachment/e6b6b9c2-dd60-488f-ac4d-727a2d9e4336/gr1_lrg.jpg)
Mechanisms, mitigation, and management of urinary toxicity from prostate radiotherapy - The Lancet Oncology
![Detection Efficacy of 18F‐rhPSMA‐7.3 PET/CT and Impact on Management in Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy and Before Potential Salvage Treatment | Journal of Nuclear Medicine Detection Efficacy of 18F‐rhPSMA‐7.3 PET/CT and Impact on Management in Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy and Before Potential Salvage Treatment | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/62/12/1719/F1.large.jpg)
Detection Efficacy of 18F‐rhPSMA‐7.3 PET/CT and Impact on Management in Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy and Before Potential Salvage Treatment | Journal of Nuclear Medicine
![Definitive external-beam radiotherapy versus radical prostatectomy in clinically localized high-risk prostate cancer: a retrospective study | BMC Urology | Full Text Definitive external-beam radiotherapy versus radical prostatectomy in clinically localized high-risk prostate cancer: a retrospective study | BMC Urology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12894-018-0432-6/MediaObjects/12894_2018_432_Fig1_HTML.png)
Definitive external-beam radiotherapy versus radical prostatectomy in clinically localized high-risk prostate cancer: a retrospective study | BMC Urology | Full Text
![Frontiers | Comparing the Survival Outcomes of Radical Prostatectomy Versus Radiotherapy for Patients With De Novo Metastasis Prostate Cancer: A Population-Based Study Frontiers | Comparing the Survival Outcomes of Radical Prostatectomy Versus Radiotherapy for Patients With De Novo Metastasis Prostate Cancer: A Population-Based Study](https://www.frontiersin.org/files/Articles/797462/fonc-11-797462-HTML/image_m/fonc-11-797462-g001.jpg)